Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to China

In 2023, the import volume of ambergris, civet, and musk for pharmaceutical use to China stood at 1.12 million kilograms. Over the forecast period from 2024 to 2028, imports are expected to grow steadily, indicating an overall positive trend. By 2028, the volume is projected to reach 1.2934 million kilograms. The Compound Annual Growth Rate (CAGR) over this five-year period reflects consistent growth.

Year-on-year growth illustrates a gradual increase, emphasizing a robust demand for these materials within the pharmaceutical industry in China. The trend suggests an opportunity for suppliers and stakeholders to capitalize on this growing market.

Future trends to watch for include potential shifts in regulatory policies affecting imports, advances in synthetic alternatives, and changes in consumer demand patterns, which could influence the import volumes of these materials.